Kenalog-10
NDC Package 68258-8903-5
Package Information
Kenalog-10 is a medication used in a variety of conditions such as allergic disorders, arthritis, gout, blood diseases, breathing problems, certain cancers, eye diseases, intestinal disorders, collagen and skin diseases. Marketed by Dispensing Solutions, Inc., this product is identified by NDC 68258-8903 and is authorized under FDA application NDA012041.
Identification & Billing
- RxCUI: 1085750 - triamcinolone acetonide 10 MG/ML Injectable Suspension
- RxCUI: 1085752 - Kenalog 10 MG/ML Injectable Suspension
- RxCUI: 1085752 - triamcinolone acetonide 10 MG/ML Injectable Suspension [Kenalog]
- RxCUI: 1085752 - Kenalog-10 10 MG/ML Injectable Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68258 - Dispensing Solutions, Inc.
- 68258-8903 - Kenalog-10
- 68258-8903-5 - 5 mL in 1 VIAL, MULTI-DOSE
- 68258-8903 - Kenalog-10
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68258-8903-5 identifies a specific commercial package of 5 ml in 1 vial, multi-dose of Kenalog-10, labeled by Dispensing Solutions, Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 5 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dispensing Solutions, Inc. on June 01, 2009. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
This medication is used in a variety of conditions such as allergic disorders, arthritis, gout, blood diseases, breathing problems, certain cancers, eye diseases, intestinal disorders, collagen and skin diseases. Talk to your doctor about the risks and benefits of triamcinolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Triamcinolone is known as a corticosteroid hormone (glucocorticoid). It works by decreasing your body's immune response to these diseases and reduces symptoms such as swelling.
How is this Dispensing Solutions, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68258890305. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.